DIY Cure? Don't Do It
Outlook|April 07, 2020
Rumours of panaceas for COVID-19 abound. But some might do more harm than good.
Ajay Sukumaran
DIY Cure? Don't Do It

After US President Trump and WhatsApp forwards endorsed the anti-malarial drug hydroxychloroquine (HCQ) to fight COVID-19, authorities and chemist associations have cautioned people against buying it—and other antiviral drugs. On March 24, the Delhi drugs control department sent out an advisory to chemists after observing that “some consumers were buying the medicines for prophylactic use”. The National Pharmaceuticals Pricing Authority of India too put out a tweet warning against self-medication. “Only by prescription, it will be sold,”

Rajiv Singhal, general secretary of the All India Organisation of Chemists and Druggists (AIOCD), told Outlook. Singhal says his association, which covers about 8.5 lakh chemists, has sent out strict instructions not to give out azithromycin, HCQ, chloroquine, lopanavir and ritonavir unless prescribed by a registered medical practitioner. “HCQ normally isn’t a medicine in high demand, but early this week there was a sudden spurt in queries,” he adds. “Rumours are creating the issue. Our doctors are doing a wonderful job and people shouldn’t panic.”

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

This story is from the {{IssueName}} edition of {{MagazineName}}.

Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.

MORE STORIES FROM OUTLOOKView all
Layers Of Lear
Outlook

Layers Of Lear

Director Rajat Kapoor and actor Vinay Pathak's ode to Shakespeare is an experience to behold

time-read
4 mins  |
December 21, 2024
Loss and Longing
Outlook

Loss and Longing

Memories can be painful, but they also make life more meaningful

time-read
6 mins  |
December 21, 2024
Suprabhatham Sub Judice
Outlook

Suprabhatham Sub Judice

M.S. Subbulakshmi decided the fate of her memorials a long time ago

time-read
8 mins  |
December 21, 2024
Fortress of Desire
Outlook

Fortress of Desire

A performance titled 'A Streetcart Named Desire', featuring Indian and international artists and performers, explored different desires through an unusual act on a full moon night at the Gwalior Fort

time-read
7 mins  |
December 21, 2024
Of Hope and Hopelessness
Outlook

Of Hope and Hopelessness

The body appears as light in Payal Kapadia's film

time-read
3 mins  |
December 21, 2024
Ruptured Lives
Outlook

Ruptured Lives

A visit to Bangladesh in 2010 shaped the author's novel, a sensitively sketched tale of migrants' struggles

time-read
5 mins  |
December 21, 2024
The Big Book
Outlook

The Big Book

The Big Book of Odia Literature is a groundbreaking work that provides readers with a comprehensive introduction to the rich and varied literary traditions of Odisha

time-read
4 mins  |
December 21, 2024
How to Refuse the Generous Thief
Outlook

How to Refuse the Generous Thief

The poet uses all the available arsenal in English to write the most anti-colonial poetry

time-read
4 mins  |
December 21, 2024
The Freedom Compartment
Outlook

The Freedom Compartment

#traindiaries is a photo journal shot in the ladies coaches of Mumbai locals. It explores how women engage and familiarise themselves with spaces by building relationships with complete strangers

time-read
1 min  |
December 21, 2024
Love, Up in the Clouds
Outlook

Love, Up in the Clouds

Manikbabur Megh is an unusual love story about a man falling for a cloud. Amborish Roychoudhury discusses the process of Manikbabu's creation with actor Chandan Sen and director Abhinandan Banerjee

time-read
5 mins  |
December 21, 2024